Search

everythinglearnresearchcommunity

for

Search:↓

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Patients at dermatology specialist hospitals had lower death and readmission rates but higher treatment costs.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Sexual activity can spread T. interdigitale, needing quick antifungal treatment to avoid permanent scarring.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

COVID-19 infection may trigger alopecia areata in some patients.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Minoxidil solution safely and effectively treats hair loss.

EtG levels in hair decrease significantly after one month of alcohol abstinence.

Lupus causes emotional and social challenges, but support from friends helps reduce depression and anxiety.

Electrospun scaffolds can improve healing in diabetic wounds.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Sudden hair loss might be a symptom of COVID-19.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.